SweetValueLab
Write for us

Incyte Corporation — Financial Statements & Ratios

INCY
NASDAQHealthcareBiotechnologyCIK 0000879169incyte.comAbout INCY
Last close · Oct 16, 2026113.07−0.20 (−0.18%)
Market cap$22.9B

Key indicators

Revenue5.4BTTM+21.5% on a year earlier+15.4% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
1.9B 2.2B+14.7%2.7B+23.5%3.0B+12.0%3.4B+13.7%3.7B+8.9%4.2B+14.8%5.1B+21.2%5.4B+21.5%5.9B 6.2B 6.5B
— 14.7% 23.5% 12.0% 13.7% 8.9% 14.8% 21.2% 21.5% 15.5% 4.7% 5.1%
$0.51 $2.05+302.0%-$1.36−166.3%$4.27+414.0%$1.52−64.4%$2.65+74.3%$0.15−94.3%$6.41+4173.3%$7.08+2522.2%$3.28 $8.17 $8.94
Profitability
6.9% 18.6%+11.8 pt-9.9%−28.5 pt19.6%+29.5 pt17.1%−2.5 pt16.8%−0.3 pt1.4%−15.3 pt29.5%+28.0 pt30.0%+26.1 pt· · ·
5.8% 20.7%+14.9 pt-11.1%−31.8 pt31.8%+42.9 pt10.0%−21.7 pt16.2%+6.1 pt0.8%−15.4 pt25.0%+24.3 pt26.7%+26.2 pt· · ·
5.7% 17.2%+11.5 pt-11.3%−28.5 pt25.2%+36.5 pt7.8%−17.4 pt11.5%+3.7 pt0.9%−10.6 pt24.9%+24.0 pt— · · ·
Cash
262.7M 632.6M+140.8%-312.0M−149.3%568.5M+282.2%892.1M+56.9%464.0M−48.0%249.1M−46.3%1.4B+443.9%1.5B+379.3%· · ·
14.0% 29.3%+15.3 pt-11.7%−41.0 pt19.0%+30.7 pt26.3%+7.2 pt12.6%−13.7 pt5.9%−6.7 pt26.3%+20.5 pt27.1%+20.2 pt· · ·
Balance sheet
9.91x — — — — — — — — · · ·
215.63M 217.66M+0.9%218.07M+0.2%222.07M+1.8%223.96M+0.8%225.93M+0.9%210.53M−6.8%200.70M−4.7%206.83M+4.4%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Mar 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.